Abstract
Drug delivery applications using biodegradable polymeric microspheres are becoming an important means of delivering therapeutic agents. The aim of this work was to modulate the microporosity of poly(ε-caprolactone) (PCL) microcarriers to control protein loading capability and release profile. PCL microparticles loaded with BSA (bovine serum albumin) have been de novo synthesized with double emulsion solvent evaporation technique transferred and adapted for different polymer concentrations (1.7 and 3% w/v) and stabilizer present in the inner aqueous phase (0.05, 0.5 and 1% w/v). SEM (scanning electron microscope) and CLSM (confocal laser scanning microscope) analysis map the drug distribution in homogeneously distributed cavities inside the microspheres with dimensions that can be modulated by varying double emulsion process parameters. The inner structure of BSA-loaded microspheres is greatly affected by the surfactant concentration in the internal aqueous phase, while a slight influence of polymer concentration in the oil phase was observed. The surfactant concentration mainly determines microspheres morphology, as well as drug release kinetics, as confirmed by our in-vitro BSA release study. Moreover, the entrapped protein remained unaltered during the protein encapsulation process, retaining its bio-activity and structure, as shown through a dedicated gel chromatographic analytical method.
Similar content being viewed by others
References
D. BLANCO and M. J. ALONSO, Eur. J. Pharm. Biopharm. 45 (1998) 285
S. P. SCHWEDERMAN, M. CARDAMONE, M. R. BRANDON, A. KLIBANOV and R. LANGER, in “Microparticulate Systems for the Delivery of Proteins and Vaccines” (Marcel Dekker, New York, 1996) p. 1
T. KISSEL, R. KONEBERG, in “Microparticulate Systems for the Delivery of Proteins and Vaccines” (Marcel Dekker, New York, 1996) p. 51
S. FREIBERG and X. X. ZHU, Intern. J. Pharm. 282 (2004) 1
M. CHIBA, J. HANES and R. LANGER, Biomaterials 18 (1997) 893
E. MATHIOWITZ, D. KLINE and R. LANGER, Scanning Microsc. 4 (1990) 329
E. MATHIOWITZ, W. M. SALTZMAN, A. DOMB and R. LANGER, J. Appl. Polym. Sci. 35 (1988) 755
J. TAMADA and R. LANGER, J. Biomater. Sci. Polym. Ed. 3 (1992) 315
I. J. CASTELLANOS, W. O. CUADRADO and K. GRIEBENOW, J. Pharm. Pharmacol. 53 (2001) 1099
S. COHEN, T. YOSHIKA, M. LUCARELLI, L. H. HWANG and R. LANGER, Pharm. Res. 8 (1991) 713
R. NARAYANI and K. PANDURANGA RAO, Int. J. Pharm. 143 (1996) 255
P. SANSDRAP and A. J. MOES, J. Control. Release. 43 (1997) 47
J. M. BEZEMER, R. RADERSMA, D. W. GRIJPMA, P. J. DIJKSTRA, C. A. VAN BLITTERSWIJK and J. FEIJEN, J. Control. Release. 67 (2000) 249
M. A. TRACY, K. L. WARD, L. FIROUZABADIAN, Y. WANG, N. DONG, R. QIAN and Y. ZHANG, Biomaterials 20 (1999) 1057
YI.-Y. YANG, T.-S. CHUNG and N. PING, Biomaterials 22 (2001) 231
M. A. BENOIT, B. BARAS and J. GILLARD, Intern. J. Pharmaceutics 184 (1999) 73
D. L. WISE, T. D. FELLMAN, J. E. SANDERSON and R. L. WENTWORTH, in “Drug Carriers in Medicine” (Academic Press, New York, 1979) p. 237
V. R. SINHA, K. BANSAL, R. KAUSHIK, R. KUMRIA and A. TREHAN, Int. J. Pharm. 278 (2004) 1
B. BOTTI, C. YOUAN, T. L. JACKSON, L. DICKENS, C. HERNANDEZ and G. O. ABABIO, J. Control. Release 76 (2001) 313
C. G. PITT, in “Biodegradable Polymers as Drug Delivery Systems” (Marcel Dekker New York 1990), p. 71
M. D. DHANARAJU, D. GOPINATH, M. R. AHMED, R. JAYAKUMAR and C. VAMSADHARA, J. Biomed. Mater. Res. 76A (2006) 63
M. VERGER, L. FLUCKIGER, Y. KIM, M. HOFFMAN, P. MAINCENT, Eur. J. Pharm. Biopharm. 46 (1998) 137
B. K. KIM, S. J. HWANG, J. B. PARK and H. J. PARK, J. Microencapsul. 22 (2005) 193
S. ZHOU, X. DENG and H. YANG, Biomaterials 24 (2003) 3563
R. L. SASTRE, M. D. BLANCO, C. TEIJÓN, R. OLMO and J. M. TEIJÓN, Drug Dev. Res. 63(2) (2004) 41
S. R. JAMEELA, N. SUMA and A. JAYAKRISHNAN, J. Biomater. Sci. Polym. Ed. 8 (1997) 457
Y. OGAWA, H. OKADA, M. YAMAMOTO and T. SHIMAMOTO, Chem. Pharm. Bull. 36 (1988) 2576
J. H. KIM and Y. H. BAE, Eur. J. Pharm. Sci. 23 (2004) 245
N. NIHANT, C. SCHUGENS, C. GRANDFILS, R. JEROME and P. TEYSSIE, J. Colloid Interface Sci. 173 (1995) 55
M. N. VRANCKEN and D. A. CLAYS, United States Patent Office, Patent No 3,526,906, (1970)
N. C. DE JAEGER and B. H. TAVERNIER, British Patent No 1,405,108 (1971)
G. CROTTS and T. G. PARK, J. Control. Release. 35 (1995) 91
T. PETERS, Adv. Prot. Chem. 37 (1985) 161
T. R. TICE, R. M. GILLEY, US patent No 5,407,609 (1993)
D. L. WISE, D. J. TRANTOLO, R. T. MARINO and J. P. KITCHELL, Adv. Drug Deliv. Rev. 1 (1987) 19
B. H. WOO, J. W. KOSTANSKI, S. GEBREKIDAN, B. A. DANI, B. C. THANOO and P. P. DELUCA, J. Control. Release. 75 (2001) 307
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coccoli, V., Luciani, A., Orsi, S. et al. Engineering of poly(ε-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J Mater Sci: Mater Med 19, 1703–1711 (2008). https://doi.org/10.1007/s10856-007-3253-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-007-3253-9